Eva Live prospectus supplement covers equity line with Hudson Global Ventures
Eva Live Inc. filed a prospectus supplement on October 19, 2026 to register shares under its September 17, 2026 Equity Purchase Agreement with Hudson Global Ventures, LLC. The agreement lets the company direct the investor to buy up to 5,000,000 shares of common stock, for up to $10 million in aggregate, and the company also issued a warrant for 275,000 shares at $0.01 per share. Shareholders may face dilution if these shares are issued.
Key points
- Equity Purchase Agreement dated September 17, 2026 allows purchases of up to 5,000,000 shares for up to $10,000,000 in aggregate
- Warrant issued to Hudson Global Ventures to buy 275,000 shares at $0.01 per share, exercisable for five years after September 17, 2026
- Shares were registered under Form S-3 (File No. 333-294416), declared effective March 24, 2026, plus a prospectus supplement filed October 19, 2026
The filing
Written by AI on Nov 9, 2026, 11:46 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on October 19, 2026.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.